Study on the influencing factors and predictive biomarkers of immune-related adverse events caused by tislelizumab in patients with malignant tumors

Zhu Hui, Yuan Yongfang, Xu Ying

PDF(660 KB)
PDF(660 KB)
Adverse Drug Reactions Journal ›› 2024, Vol. 26 ›› Issue (1) : 18-24. DOI: 10.3760/cma.j.cn114015-20230803-00582

Study on the influencing factors and predictive biomarkers of immune-related adverse events caused by tislelizumab in patients with malignant tumors

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 26(1): 18-24 https://doi.org/10.3760/cma.j.cn114015-20230803-00582

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(660 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉